Neuropathy;Peripheral Clinical Trial
Official title:
Clinical Efficacy and Human Factors Validation Testing for Prescription Home Use of the Erchonia Corporation EVRL™ for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot Pain
The purpose of this clinical study is to determine the effectiveness of the Erchonia® EVRL™, manufactured by Erchonia Corporation (the Company), in providing prescription home use application for temporary relief of diabetic neuropathy foot pain in individuals diagnosed with diabetic neuropathy by a suitably qualified and licensed health professional.
Human Factors Validation Testing will initially be conducted to valuate a lay person's ability to understand and apply as applicable the information contained in the EVRL™ Use Device Proper Use Reference Guide, and device packaging and labeling materials to correctly, safely, and successfully activate and operate the EVRL™ to administer the treatment; and to identify any and all use difficulties, problems and errors, including those pertaining to critical tasks and close calls demonstrated by the lay person during device operation, and to subsequently mitigate each identified instance of use error through device and/or materials modification, and to subsequently evaluate the effectiveness of each modification, as applicable Phase Two will commence following the successful completion of Phase One. Phase Two comprises the performance of a double-blind, randomized, placebo-controlled, clinical study of the efficacy of the Erchonia® EVRL™, manufactured by Erchonia Corporation (the Sponsor), for prescription home use application in providing temporary relief of diabetic peripheral neuropathy foot pain. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04699734 -
Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy
|
N/A | |
Completed |
NCT04054804 -
Digital Foot Check by Using the D-Foot, a New Software
|
||
Completed |
NCT05161364 -
Kinetic Analysis Due to Foot Dysfunction
|
||
Not yet recruiting |
NCT03899298 -
Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions
|
Phase 1 | |
Completed |
NCT02970006 -
Investigating Mechanisms Underlying Spinal Cord Stimulation Efficacy Using Virtual Reality and Full Body Illusion
|
N/A | |
Recruiting |
NCT05291286 -
BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients
|
Early Phase 1 | |
Recruiting |
NCT04403802 -
Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy
|
N/A | |
Enrolling by invitation |
NCT05590117 -
Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer
|
Early Phase 1 | |
Recruiting |
NCT05624138 -
The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy
|
Phase 3 | |
Recruiting |
NCT06121232 -
Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study
|
N/A | |
Recruiting |
NCT05065554 -
ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy
|
Phase 2 | |
Recruiting |
NCT05980767 -
Short Duration Electrical Stimulation to Improve Outcomes After Cubital Tunnel Release (SELECT) Trial
|
N/A | |
Completed |
NCT03135535 -
Micro-mobile Foot Compression and Diabetic Foot
|
Phase 2 | |
Recruiting |
NCT03037684 -
Depolarising Electrical Skin Stimulation in Neuropathic and Postoperative Pain
|
||
Recruiting |
NCT04865185 -
Effect of Topical Lidocaine on Warm and Cold Sensation in Healthy Individuals
|
N/A | |
Completed |
NCT05093023 -
ABCB1 SNPs as Predictors of PIPN
|
||
Completed |
NCT05410548 -
Comorbidity Screening and Referral by Prosthetists
|
N/A | |
Completed |
NCT03021174 -
Exercise and Nutrition Interventions During Chemotherapy
|
N/A | |
Not yet recruiting |
NCT06422949 -
Efficacy and Safety of HILOTERM® Device for the Prevention of Peripheral Neuropathy
|
N/A | |
Terminated |
NCT03777956 -
The Effect of Lacosamide in Peripheral Neuropathic Pain
|
Phase 2 |